Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry

Background and Objective: Oral anticoagulation (OAC) for secondary stroke prevention is recommended in atrial fibrillation (AF) and other sources of cardioembolic stroke. Our objectives were to explore the differences in ischemic and hemorrhagic events when using OAC for secondary stroke prevention...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Neurol
Main Authors: Gutiérrez-Zúñiga, Raquel, Rigual, Ricardo, Torres-Iglesias, Gabriel, Sánchez-Velasco, Sara, Alonso de Leciñana, María, Masjuan, Jaime, Álvarez Velasco, Rodrigo, Navas, Inmaculada, Izquierdo-Esteban, Laura, Fernández-Ferro, José, Rodríguez-Pardo, Jorge, Ruiz-Ares, Gerardo, Zapata-Wainberg, Gustavo, Fuentes, Blanca, Díez-Tejedor, Exuperio
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Neurology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7641639/
https://ncbi.nlm.nih.gov/pubmed/33193025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.575634
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki